In a recent study examining the effects of CAPE on AD pathology and cognitive functions in AβO-injected mice [61], CAPE, intraperitoneally administered for 10 days, significantly reversed spatial memory impairment, measured using the MWM test. This evidence concerns the gene ABO and Alzheimer disease.